AFL · Aflac Inc
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| 12-Mo. Rolling Premium Persistency | 79.4% | 2 (2026) | — |
| Adjusted book value non-GAAP | $27.63B | June 30, 2026 | — |
| Adjusted debt non-GAAP | $7.79B | June 30, 2026 | — |
| Adjusted debt to adjusted capitalization non-GAAP | 25.3% | June 30, 2026 | — |
| Adjusted earnings non-GAAP | 1.78B | six months ended June 30, 2026 | — |
| Adjusted earnings excluding current period foreign currency impact non-GAAP | 1.82B | six months ended June 30, 2026 | — |
| Adjusted earnings per diluted share non-GAAP | $3.5 | six months ended June 30, 2026 | — |
| Adjusted earnings per diluted share excluding current period foreign currency impact non-GAAP | $3.57 | six months ended June 30, 2026 | — |
| Adjusted Leverage Ratio non-GAAP | 21.8% | 2Q26 | — |
| Adjusted ROE non-GAAP | 16.6% | 2Q26 | — |
| Adjusted ROE ex Foreign Currency Remeasurement non-GAAP | 12.7% | 2Q26 | — |
| Aflac Inc. unencumbered liquidity | $3.3B | 2Q26 | — |
| Aflac Japan pretax adjusted profit margin non-GAAP | 34.3% | 2Q26 | — |
|
|
|||
| Aflac Japan total new annualized premium sales | ¥19.6B | 2Q26 | — |
|
|
|||
| Aflac U.S. pretax adjusted profit margin non-GAAP | 20.9% | 2Q26 | — |
|
|
|||
| Aflac U.S. sales | $349M | 2Q26 | — |
|
|
|||
| Annualized adjusted return on equity excluding foreign currency remeasurement non-GAAP | 16.6% | 2Q26 | — |
| Annualized Premiums In Force | $6.8B | 2 (2026) | — |
| Annualized return on average shareholders' equity | 10.9% | 2Q26 | — |
|
|
|||
| Benefit Ratio | 49.5% | 2Q26 | — |
| Dividends | $309M | 2Q26 | — |
| Expense Ratio | 36.1% | 2Q26 | — |
| New Annualized Premiums Sales | $349M | 2 (2026) | — |
| Portfolio repositioned through switch trades | $4.8B | 2Q26 | — |
| Pretax adjusted earnings non-GAAP | $733M | 6 Months Ended June 30, 2026 | — |
| Pretax Profit Margin non-GAAP | 20.9% | 2Q26 | — |
| Regulatory ESR | 226% | 2Q26 | — |
| Regulatory ESR with USP | 240% | 2Q26 | — |
| Share Repurchase | $983M | 2Q26 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Insurance - Life — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AFL
this stock
Aflac Inc
|
$61.03B | +5.7% | -9.3% | 13.1 | 2.5% |
|
CILJF
China Life Insurance Co Ltd
|
$97.80B | +0.4% | — | — | 0.0% |
|
MFC
Manulife Financial Corp
|
$73.51B | +19.7% | — | — | 0.8% |
|
MET
Metlife Inc
|
$61.44B | +20.5% | +8.6% | 18.5 | 1.8% |
|
GWLIF
Great-West Lifeco Inc.
|
$58.30B | +31.6% | — | — | 0.4% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AFL | -3.5% | -5.7% | +2.2% | -8.6% | +5.7% |
| SPY | -0.4% | +2.9% | +11.6% | +3.0% | +12.8% |
| vs SPY | -3.1% | -8.6% | -9.3% | -11.6% | -7.1% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.